Literature DB >> 1975104

Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.

J L Waddington1.   

Abstract

While understanding of the major clinical and ethical issue of tardive dyskinesia would be greatly facilitated by the development of an isomorphic or homologous animal model, particularly in rodents, this has proved to be a highly contentious issue. The literature on orofacial function in rats administered neuroleptic drugs for substantial proportions of their adult lifespan is reviewed. It reveals the emergence of late-onset orofacial movements in a number of studies, but very early-onset movements or no effect in others. Potential explanations for these discrepancies are considered, and ways of resolving such inconsistencies are suggested. The relationship of these various orofacial phenomena to dopaminergic and non-dopaminergic function, and to clinical syndromes, is critically evaluated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975104     DOI: 10.1007/bf02244220

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  64 in total

1.  Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model.

Authors:  L A Rodriguez; D E Moss; E Reyes; M L Camarena
Journal:  Pharmacol Biochem Behav       Date:  1986-12       Impact factor: 3.533

Review 2.  The effect of chronic neuroleptic administration on cerebral dopamine receptor function.

Authors:  M N Rupniak; P Jenner; C D Marsden
Journal:  Life Sci       Date:  1983-05-16       Impact factor: 5.037

3.  Induction of oral dyskinesias in naive rats by D1 stimulation.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1983-12-19       Impact factor: 5.037

4.  Drug holidays alter onset of oral movements in rats following chronic haloperidol.

Authors:  W W Sant; G Ellison
Journal:  Biol Psychiatry       Date:  1984-01       Impact factor: 13.382

5.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

6.  Schizophrenia, tardive dyskinesia, and brain GABA.

Authors:  T L Perry; S Hansen; K Jones
Journal:  Biol Psychiatry       Date:  1989-01-15       Impact factor: 13.382

Review 7.  Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

Authors:  J M Kane; J M Smith
Journal:  Arch Gen Psychiatry       Date:  1982-04

8.  Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.

Authors:  L M Gunne; J E Häggström; B Sjöquist
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

9.  Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.

Authors:  J L Waddington; H A Youssef; C Dolphin; A Kinsella
Journal:  Arch Gen Psychiatry       Date:  1987-10

10.  Chronic haloperidol effects on oral movements and radial-arm maze performance in rats.

Authors:  E D Levin; D M Galen; G D Ellison
Journal:  Pharmacol Biochem Behav       Date:  1987-01       Impact factor: 3.533

View more
  35 in total

1.  Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias.

Authors:  G E Meredith; I E De Souza; T M Hyde; G Tipper; M L Wong; M F Egan
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.

Authors:  Tanuja Bordia; J Michael McIntosh; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2011-12-05       Impact factor: 4.030

3.  Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.

Authors:  Ian E J De Souza; Niamh M Dawson; Jeremiah J Clifford; John L Waddington; Gloria E Meredith
Journal:  Psychopharmacology (Berl)       Date:  2003-06-27       Impact factor: 4.530

4.  Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment.

Authors:  P R Buckland; M C O'Donovan; P McGuffin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Drug-induced oral dyskinesias in rats after traditional and new neuroleptics.

Authors:  T Kakigi; X M Gao; C A Tamminga
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine.

Authors:  R E Steinpreis; P Baskin; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Effect of chronic trifluoperazine administration and subsequent withdrawal on the production and persistence of perioral behaviours in two rat strains.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats.

Authors:  O A Andreassen; H A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

10.  Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.

Authors:  T M Hyde; M F Egan; L L Wing; R J Wyatt; D R Weinberger; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.